Search Results - "CHEVALIER, Bernard"

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk by Valgimigli, Marco, Frigoli, Enrico, Heg, Dik, Tijssen, Jan, Jüni, Peter, Vranckx, Pascal, Ozaki, Yukio, Morice, Marie-Claude, Chevalier, Bernard, Onuma, Yoshinobu, Windecker, Stephan, Tonino, Pim A.L, Roffi, Marco, Lesiak, Maciej, Mahfoud, Felix, Bartunek, Jozef, Hildick-Smith, David, Colombo, Antonio, Stanković, Goran, Iñiguez, Andrés, Schultz, Carl, Kornowski, Ran, Ong, Paul J.L, Alasnag, Mirvat, Rodriguez, Alfredo E, Moschovitis, Aris, Laanmets, Peep, Donahue, Michael, Leonardi, Sergio, Smits, Pieter C

“…One month after the implantation of biodegradable-polymer sirolimus-eluting coronary stents, patients at high bleeding risk were randomly assigned to stop dual…”
Get full text

Contemporary Approach to Coronary Bifurcation Lesion Treatment by Sawaya, Fadi J., MD, Lefèvre, Thierry, MD, Chevalier, Bernard, MD, Garot, Phillipe, MD, Hovasse, Thomas, MD, Morice, Marie-Claude, MD, Rab, Tanveer, MD, Louvard, Yves, MD

“…Abstract Coronary bifurcations are frequent and account for approximately 20% of all percutaneous coronary interventions. Nonetheless, they remain one of the…”
Get full text

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial by Serruys, Patrick W, Prof, Chevalier, Bernard, MD, Sotomi, Yohei, MD, Cequier, Angel, MD, Carrié, Didier, Prof, Piek, Jan J, Prof, Van Boven, Ad J, MD, Dominici, Marcello, Prof, Dudek, Dariusz, MD, McClean, Dougal, MD, Helqvist, Steffen, MD, Haude, Michael, Prof, Reith, Sebastian, MD, de Sousa Almeida, Manuel, MD, Campo, Gianluca, MD, Iñiguez, Andrés, MD, Sabaté, Manel, MD, Windecker, Stephan, Prof, Onuma, Yoshinobu, MD

“…Summary Background No medium-term data are available on the random comparison between everolimus-eluting bioresorbable vascular scaffolds and…”
Get full text

Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis by Yoon, Sung-Han, Bleiziffer, Sabine, De Backer, Ole, Delgado, Victoria, Arai, Takahide, Ziegelmueller, Johannes, Barbanti, Marco, Sharma, Rahul, Perlman, Gidon Y., Khalique, Omar K., Holy, Erik W., Saraf, Smriti, Deuschl, Florian, Fujita, Buntaro, Ruile, Philipp, Neumann, Franz-Josef, Pache, Gregor, Takahashi, Masao, Kaneko, Hidehiro, Schmidt, Tobias, Ohno, Yohei, Schofer, Niklas, Kong, William K.F., Tay, Edgar, Sugiyama, Daisuke, Kawamori, Hiroyuki, Maeno, Yoshio, Abramowitz, Yigal, Chakravarty, Tarun, Nakamura, Mamoo, Kuwata, Shingo, Yong, Gerald, Kao, Hsien-Li, Lee, Michael, Kim, Hyo-Soo, Modine, Thomas, Wong, S. Chiu, Bedgoni, Francesco, Testa, Luca, Teiger, Emmanuel, Butter, Christian, Ensminger, Stephan M., Schaefer, Ulrich, Dvir, Danny, Blanke, Philipp, Leipsic, Jonathon, Nietlispach, Fabian, Abdel-Wahab, Mohamed, Chevalier, Bernard, Tamburino, Corrado, Hildick-Smith, David, Whisenant, Brian K., Park, Seung-Jung, Colombo, Antonio, Latib, Azeem, Kodali, Susheel K., Bax, Jeroen J., Søndergaard, Lars, Webb, John G., Lefèvre, Thierry, Leon, Martin B., Makkar, Raj

“…Transcatheter aortic valve replacement (TAVR) is being increasingly performed in patients with bicuspid aortic valve stenosis (AS). This study sought to…”
Get full text

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial by Serruys, Patrick W, Prof, Chevalier, Bernard, MD, Dudek, Dariusz, MD, Cequier, Angel, MD, Carrié, Didier, MD, Iniguez, Andres, MD, Dominici, Marcello, MD, van der Schaaf, René J, MD, Haude, Michael, MD, Wasungu, Luc, PhD, Veldhof, Susan, RN, Peng, Lei, MSc, Staehr, Peter, MD, Grundeken, Maik J, MD, Ishibashi, Yuki, MD, Garcia-Garcia, Hector M, MD, Onuma, Yoshinobu, MD

“…Summary Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for treatment for coronary artery disease, no data from…”
Get full text

Prognostic Value of Chronic Kidney Disease After Transcatheter Aortic Valve Implantation by Yamamoto, Masanori, MD, PhD, Hayashida, Kentaro, MD, PhD, Mouillet, Gauthier, MD, Hovasse, Thomas, MD, Chevalier, Bernard, MD, Oguri, Atsushi, MD, PhD, Watanabe, Yusuke, MD, Dubois-Randé, Jean-Luc, MD, PhD, Morice, Marie-Claude, MD, Lefèvre, Thierry, MD, Teiger, Emmanuel, MD, PhD

“…Objectives This study sought to assess the influence of chronic kidney disease (CKD) classification on clinical outcomes in patients undergoing transcatheter…”
Get full text

Sex-Related Differences in Clinical Presentation and Outcome of Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis by Hayashida, Kentaro, MD, PhD, Morice, Marie-Claude, MD, Chevalier, Bernard, MD, Hovasse, Thomas, MD, Romano, Mauro, MD, Garot, Philippe, MD, Farge, Arnaud, MD, Donzeau-Gouge, Patrick, MD, Bouvier, Erik, MD, Cormier, Bertrand, MD, Lefèvre, Thierry, MD

“…Objectives The purpose of this study was to clarify the impact of sex-related differences in transcatheter aortic valve implantation (TAVI) for high-risk…”
Get full text

Kissing Balloon Inflation in Percutaneous Coronary Interventions by Sgueglia, Gregory A., MD, PhD, Chevalier, Bernard, MD

“…Bifurcation lesions are the most frequently approached complex coronary lesions in everyday interventional practice. Bifurcations complexity relies essentially…”
Get full text

Impact of Post-Procedural Aortic Regurgitation on Mortality After Transcatheter Aortic Valve Implantation by Hayashida, Kentaro, MD, PhD, Lefèvre, Thierry, MD, Chevalier, Bernard, MD, Hovasse, Thomas, MD, Romano, Mauro, MD, Garot, Philippe, MD, Bouvier, Erik, MD, Farge, Arnaud, MD, Donzeau-Gouge, Patrick, MD, Cormier, Bertrand, MD, Morice, Marie-Claude, MD

“…Objectives The goal of the study was to clarify the impact of post-procedural aortic regurgitation (post-AR) grade 2/4 on clinical outcomes. Background Post-AR…”
Get full text

Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve Replacement by Arai, Takahide, MD, Romano, Mauro, MD, Lefèvre, Thierry, MD, Hovasse, Thomas, MD, Farge, Arnaud, MD, Le Houerou, Daniel, MD, Hayashida, Kentaro, MD, PhD, Watanabe, Yusuke, MD, Garot, Philippe, MD, Benamer, Hakim, MD, Unterseeh, Thierry, MD, Bouvier, Erik, MD, Morice, Marie-Claude, MD, Chevalier, Bernard, MD

“…Abstract Objectives The aim of this study was to compare outcomes among transfemoral (TF), transaortic (TAo), and transapical (TA) transcatheter aortic valve…”
Get full text

Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis by Yoon, Sung-Han, MD, Lefèvre, Thierry, MD, Ahn, Jung-Ming, MD, Perlman, Gidon Y., MD, Dvir, Danny, MD, Latib, Azeem, MD, Barbanti, Marco, MD, Deuschl, Florian, MD, De Backer, Ole, MD, Blanke, Philipp, MD, Modine, Thomas, MD, Pache, Gregor, MD, Neumann, Franz-Josef, MD, Ruile, Philipp, MD, Arai, Takahide, MD, Ohno, Yohei, MD, Kaneko, Hidehiro, MD, Tay, Edgar, MD, Schofer, Niklas, MD, Holy, Erik W., MD, Luk, Ngai H.V., MD, Yong, Gerald, MD, Lu, Qingsheng, MD, Kong, William K.F., MD, Hon, Jimmy, MD, Kao, Hsien-Li, MD, Lee, Michael, MD, Yin, Wei-Hsian, MD, Park, Duk-Woo, MD, Kang, Soo-Jin, MD, Lee, Seung-Whan, MD, Kim, Young-Hak, MD, Lee, Cheol Whan, MD, Park, Seong-Wook, MD, Kim, Hyo-Soo, MD, Butter, Christian, MD, Khalique, Omar K., MD, Schaefer, Ulrich, MD, Nietlispach, Fabian, MD, Kodali, Susheel K., MD, Leon, Martin B., MD, Ye, Jian, MD, Chevalier, Bernard, MD, Leipsic, Jonathon, MD, Delgado, Victoria, MD, Bax, Jeroen J., MD, Tamburino, Corrado, MD, Colombo, Antonio, MD, Søndergaard, Lars, MD, Webb, John G., MD, Park, Seung-Jung, MD

“…Abstract Background Few studies have evaluated the clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve…”
Get full text

Cerium intermetallics CeTX – review III by Pöttgen, Rainer, Janka, Oliver, Chevalier, Bernard

“…The structure–property relationships of Ce intermetallics with structures other than the ZrNiAl and TiNiSi type are systematically reviewed. These Ce phases…”
Get full text

A Clinical and Angiographic Scoring System to Predict the Probability of Successful First-Attempt Percutaneous Coronary Intervention in Patients With Total Chronic Coronary Occlusion by Alessandrino, Giuseppe, MD, Chevalier, Bernard, MD, Lefèvre, Thierry, MD, Sanguineti, Francesca, MD, Garot, Philippe, MD, Unterseeh, Thierry, MD, Hovasse, Thomas, MD, Morice, Marie-Claude, MD, Louvard, Yves, MD

“…Abstract Objectives This study sought to develop a scoring model predicting percutaneous coronary intervention (PCI) success in chronic total occlusions…”
Get full text

Renal Function–Based Contrast Dosing Predicts Acute Kidney Injury Following Transcatheter Aortic Valve Implantation by Yamamoto, Masanori, MD, PhD, Hayashida, Kentaro, MD, PhD, Mouillet, Gauthier, MD, Chevalier, Bernard, MD, Meguro, Kentaro, MD, PhD, Watanabe, Yusuke, MD, Dubois-Rande, Jean-Luc, MD, PhD, Morice, Marie-Claude, MD, Lefèvre, Thierry, MD, Teiger, Emmanuel, MD, PhD

“…Objectives This study sought to assess whether the volume of contrast media (CM) influences the occurrence of acute kidney injury (AKI) following transcatheter…”
Get full text

The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial by Suwannasom, Pannipa, MD, Sotomi, Yohei, MD, Ishibashi, Yuki, MD, PhD, Cavalcante, Rafael, MD, PhD, Albuquerque, Felipe N., MD, Macaya, Carlos, MD, Ormiston, John A., MD, Hill, Jonathan, MD, Lang, Irene M., MD, Egred, Mohaned, MD, Fajadet, Jean, MD, Lesiak, Maciej, MD, Tijssen, Jan G., MD, PhD, Wykrzykowska, Joanna J., MD, PhD, de Winter, Robbert J., MD, PhD, Chevalier, Bernard, MD, Serruys, Patrick W., MD, PhD, Onuma, Yoshinobu, MD, PhD

“…Abstract Objectives The study sought to investigate the relationship between post-procedural asymmetry, expansion, and eccentricity indices of metallic…”
Get full text

Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months by Serruys, Patrick W, Onuma, Yoshinobu, Garcia-Garcia, Hector M, Muramatsu, Takashi, van Geuns, Robert-Jan, de Bruyne, Bernard, Dudek, Dariusz, Thuesen, Leif, Smits, Pieter C, Chevalier, Bernard, McClean, Dougal, Koolen, Jacques, Windecker, Stephan, Whitbourn, Robert, Meredith, Ian, Dorange, Cecile, Veldhof, Susan, Hebert, Karine Miquel, Rapoza, Richard, Ormiston, John A

“…To assess observations with multimodality imaging of the Absorb bioresorbable everolimus-eluting vascular scaffold performed in two consecutive cohorts of…”
Get full text

Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II) by Ishibashi, Yuki, MD, PhD, Nakatani, Shimpei, MD, Sotomi, Yohei, MD, Suwannasom, Pannipa, MD, Grundeken, Maik J., MD, Garcia-Garcia, Hector M., MD, PhD, Bartorelli, Antonio L., MD, Whitbourn, Robert, MD, Chevalier, Bernard, MD, Abizaid, Alexandre, MD, PhD, Ormiston, John A., MB, ChB, PhD, Rapoza, Richard J., PhD, Veldhof, Susan, RN, Onuma, Yoshinobu, MD, PhD, Serruys, Patrick W., MD, PhD

“…Abstract Objectives This study sought to investigate the clinical outcomes based on the assessment of quantitative coronary angiography–maximal lumen diameter…”
Get full text

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled by Abizaid, Alexandre, Ribamar Costa, Jr, J, Bartorelli, Antonio L, Whitbourn, Robert, van Geuns, Robert Jan, Chevalier, Bernard, Patel, Tejas, Seth, Ashok, Stuteville, Marrianne, Dorange, Cécile, Cheong, Wai-Fung, Sudhir, Krishnankutty, Serruys, Patrick W

“…The safety and performance of the Absorb Bioresorbable Vascular Scaffold (Absorb BVS) system (Abbott Vascular, Santa Clara, CA, USA) has been previously…”
Get full text

Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world by Arai, Takahide, MD, Lefèvre, Thierry, MD, FESC, FSCAI, Hovasse, Thomas, MD, Morice, Marie-Claude, MD, FACC, FESC, Garot, Philippe, MD, Benamer, Hakim, MD, Unterseeh, Thierry, MD, Hayashida, Kentaro, MD, PhD, FESC, Watanabe, Yusuke, MD, Bouvier, Erik, MD, Cormier, Bertrand, MD, Chevalier, Bernard, MD, FESC, FSCAI

“…Abstract Background The SAPIEN 3 (S3; Edwards Lifescience, Irvine, CA, USA) is a new-generation percutaneous aortic valve with better profile, more precise…”
Get full text

Why Are We Still Using Coronary Bare-Metal Stents? by Morice, Marie-Claude, MD, Urban, Philip, MD, Greene, Samantha, BA, Schuler, Gerhard, MD, Chevalier, Bernard, MD

“…Eight indications for using BMS were identified: large vessel diameter, 241 (32.4%); ST-segment elevation myocardial infarction, 132 (17.7%);…”
Get full text